Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

AI-Driven Therapeutics

SME

ai-dt.deLeipzig, Germany
6 profile visits

About

At AI-DT, we believe that breakthrough science shouldn't be limited by the complexity of the tools behind it. We're a German biotech startup on a mission to democratize access to state-of-the-art protein design tools and computational pipelines, making them available to researchers, startups, and organizations of every size.

Today, setting up and maintaining advanced protein design tools and AI-driven pipelines is incredibly resource-intensive. It requires specialized infrastructure, deep technical expertise, and significant time investment. This creates a barrier that keeps many talented scientists and teams from leveraging the most powerful methods available.

Our CoScientist platform changes that. It brings the full power of AI-driven protein design and drug discovery into a single, intuitive interface. What once required months of complex computational setup and work can now be accomplished in days, with just one chat.

Whether you're engineering novel proteins, optimizing biologics, or exploring new therapeutic targets, our scalable, on-demand platform removes the technical barriers and lets you focus on what matters most: the science.

We're not just building faster pipelines. We're leveling the playing field so that the next breakthrough can come from anywhere.

What is your business/industry sector?

Biotech, Pharma and Cosmetics

Representatives

Ivan Ivanikov

CTO

AI-Driven Therapeutics

Marketplace (1)

  • Expertise

    Get Your Own Computational Protein Design Department

    Get Your Own Computational Protein Design Department. AI-DT gives you instant access to AI-powered protein design, enzyme engineering, antibody design, and ligand docking tools.

    • Biotech, Pharma and Cosmetics
    Author

    Ivan Ivanikov

    CTO at AI-Driven Therapeutics

    Leipzig, Germany